ALEXANDRIA, Va., March 19 -- United States Patent no. 12,252,531, issued on March 18, was assigned to Scholar Rock Inc. (Cambridge, Mass.).
"Methods of screening for high-affinity, isoform-selective TGFBeta1 inhibitors" was invented by Abhishek Datta (Boston), Allan Capili (Somerville, Mass.), Thomas Schurpf (Cambridge, Mass.), Constance Martin (Arlington, Mass.), Kevin B. Dagbay (Brighton, Mass.), Christopher Chapron (Watertown, Mass.), Stefan Wawersik (Westborough, Mass.), Christopher Littlefield (Marblehead, Mass.), Gregory J. Carven (Maynard, Mass.), Alan Buckler (Arlington, Mass.), Susan Lin (Boston), Justin W. Jackson (Cambridge, Mass.), Caitlin Stein (Lebanon, N.H.), Andrew Avery (Lebanon, N.H.), Anthony Cooper (White River Junction...